Recombinant human parathyroid hormone 1-84 for the treatment of adults with chronic hypoparathyroidism: Six-year safety and efficacy results of the RACE study

Safety And Efficacy ◽

Abstract #221 Safety and Efficacy of Recombinant Human Parathyroid Hormone 1-84 for the Treatment of Adults with Chronic Hypoparathyroidism: six-Year Results of the Race Study

Endocrine Practice ◽

10.1016/s1530-891x(20)46565-6 ◽

2019 ◽

Vol 25 ◽

pp. 75

Author(s):

Henry Bone ◽

Bart L. Clarke

Keyword(s):

Parathyroid Hormone ◽

Safety And Efficacy ◽

OR30-1 Safety and Efficacy of Recombinant Human Parathyroid Hormone 1-84 for the Treatment of Adults with Chronic Hypoparathyroidism: Six-Year Results of the RACE Study

Journal of the Endocrine Society ◽

10.1210/js.2019-or30-1 ◽

2019 ◽

Vol 3 (Supplement_1) ◽

Cited By ~ 1

Author(s):

John Bilezikian ◽

Henry Bone ◽

Bart Clarke ◽

Douglas Denham ◽

Hak-Myung Lee ◽

...

Keyword(s):

Parathyroid Hormone ◽

Safety And Efficacy ◽

Abstract #511 Comparison of 3-Year Estimated Glomerular Filtration Rates Between Recombinant Human Parathyroid Hormone (1-84) (RHPTH[1-84])-Treated Patients with Chronic Hypoparathyroidism and a Historical Control Cohort

Endocrine Practice ◽

10.1016/s1530-891x(20)47188-5 ◽

2018 ◽

Vol 24 ◽

pp. 111

Author(s):

Kristina Chen ◽

Fan Mu ◽

Elyse Swallow ◽

Jing Zhao ◽

Jessie Wang ◽

...

Keyword(s):

Parathyroid Hormone ◽

Glomerular Filtration ◽

Historical Control ◽

Control Cohort ◽

Estimated Glomerular Filtration Rates ◽

Three-year safety and efficacy data for recombinant human parathyroid hormone, rhPTH(1-84), in the treatment of adults with hypoparathyroidism: the RACE study

Endocrine Abstracts ◽

10.1530/endoabs.37.oc3.5 ◽

2015 ◽

Cited By ~ 1

Author(s):

Bart L Clarke ◽

Michael Mannstadt ◽

Tamara J Vokes ◽

Jeffrey Rothman ◽

Mark L Warren ◽

...

Keyword(s):

Parathyroid Hormone ◽

Efficacy Data ◽

Safety And Efficacy

Five-year efficacy and safety of recombinant human parathyroid hormone 1-84 (rhPTH[1-84]) for the treatment of adults with chronic hypoparathyroidism: analysis from the open-label race study

Endocrine Abstracts ◽

10.1530/endoabs.56.gp180 ◽

2018 ◽

Author(s):

Bart L Clarke ◽

Dolores M Shoback ◽

John P Bilezikian ◽

Henry Bone ◽

Douglas Denham ◽

...

Keyword(s):

Parathyroid Hormone ◽

Efficacy And Safety ◽

Open Label ◽

Safety and Efficacy of Oral Human Parathyroid Hormone (1‐34) in Hypoparathyroidism: An Open‐Label Study

Journal of Bone and Mineral Research ◽

10.1002/jbmr.4274 ◽

2021 ◽

Author(s):

Sofia Ish‐Shalom ◽

Yoseph Caraco ◽

Nariman Saba Khazen ◽

Michal Gershinsky ◽

Auryan Szalat ◽

...

Keyword(s):

Parathyroid Hormone ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Faculty Opinions recommendation of Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.3231958.2916056 ◽

2010 ◽

Author(s):

Gordon Klein

Keyword(s):

Parathyroid Hormone ◽

Randomized Trial ◽

Term Treatment ◽

Long Term Treatment ◽

Faculty Opinions recommendation of Safety and efficacy of 5 years of treatment with recombinant human parathyroid hormone in adults with hypoparathyroidism.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.736322841.793576359 ◽

2020 ◽

Author(s):

Mishaela Rubin

Keyword(s):

Parathyroid Hormone ◽

Safety And Efficacy

Renal function change in chronic hypoparathyroidism patients treated with recombinant human parathyroid hormone (1-84) (rhPTH[1-84]) and in a historical control cohort treated with standard therapy

Endocrine Abstracts ◽

10.1530/endoabs.56.oc3.4 ◽

2018 ◽

Author(s):

Kristina Chen ◽

Mishaela Rubin ◽

Fan Mu ◽

Elyse Swallow ◽

Jing Zhao ◽

...

Keyword(s):

Renal Function ◽

Parathyroid Hormone ◽

Standard Therapy ◽

Historical Control ◽

Control Cohort ◽

Function Change ◽

Abstract #532 Five-Year Efficacy and Safety of Recombinant Human Parathyroid Hormone 1-84 (RHPTH[1-84]) For The Treatment of Adults with Chronic Hypoparathyroidism

Endocrine Practice ◽

10.1016/s1530-891x(20)47209-x ◽

2018 ◽

Vol 24 ◽

pp. 124

Author(s):

Tamara Vokes ◽

John Bilezikian ◽

Henry Bone ◽

Bart Clarke ◽

Douglas Denham ◽

...

Keyword(s):

Parathyroid Hormone ◽

Efficacy And Safety ◽